pimozide has been researched along with fluphenazine depot in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bonomo, V; Parisi, R; Rapisarda, V | 1 |
| Beal, MF; Martin, JB | 1 |
| Mackie, M; McCreadie, RG; McKane, JP | 1 |
| Katz, K; Shepherd, M; Watt, DC | 1 |
| Barnes, TR; Curson, DA; Milavic, G; Platt, SD | 1 |
| Kidd, J; Mackie, M; McCreadie, R; Morrison, D | 1 |
3 trial(s) available for pimozide and fluphenazine depot
| Article | Year |
|---|---|
Weekly pimozide versus fluphenazine decanoate in schizophrenic out-and day-patients.
Topics: Clinical Trials as Topic; Double-Blind Method; Female; Fluphenazine; Humans; Male; Pimozide; Schizophrenia | 1983 |
The natural history of schizophrenia: a 5-year prospective follow-up of a representative sample of schizophrenics by means of a standardized clinical and social assessment.
Topics: Clinical Trials as Topic; Female; Fluphenazine; Follow-Up Studies; Humans; Male; Patient Readmission; Pimozide; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Social Adjustment | 1983 |
Use of the Social Behaviour Assessment Schedule (SBAS) in a trial of maintenance antipsychotic therapy in schizophrenic outpatients: pimozide versus fluphenazine.
Topics: Adult; Clinical Trials as Topic; Female; Fluphenazine; Humans; Male; Middle Aged; Outpatients; Pimozide; Schizophrenia; Social Behavior | 1983 |
4 other study(ies) available for pimozide and fluphenazine depot
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Long-acting therapy of schizophrenia.
Topics: Adolescent; Adult; Antiparkinson Agents; Benzodiazepines; Biofeedback, Psychology; Bromocriptine; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Pimozide; Schizophrenia; Trimeprazine | 1985 |
Effects of neuroleptic drugs on brain somatostatin-like-immunoreactivity.
Topics: Animals; Antipsychotic Agents; Apomorphine; Brain Chemistry; Chlorpromazine; Fluphenazine; Haloperidol; Male; Peptides; Pimozide; Rats; Rats, Inbred Strains; Time Factors | 1984 |
Once weekly pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
Topics: Adult; Aged; Chronic Disease; Double-Blind Method; Dyskinesia, Drug-Induced; Fluphenazine; Humans; Male; Middle Aged; Pimozide; Prolactin; Schizophrenia | 1982 |